The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease

Revise to specify the mechanisms by which dyslipidemia and creeping fat serve as biomarkers.

Expand on the clinical significance of lipid metabolism and creeping fat in managing Crohn's Disease.

Remove the statement about no numerical data; summarize key findings quantitatively if available.

Creeping fat is characterized by mesenteric fat expansion and bowel wrapping, contributing to intestinal inflammation and fibrosis.
Dyslipidemia during the active phase of CD correlates with systemic inflammation severity.
Current imaging techniques can assess creeping fat to predict surgical risks and postoperative recurrence.
Lipid levels and creeping fat may serve as potential biomarkers for evaluating disease activity in CD.
Long-term follow-up studies indicate a high cumulative incidence of disability in CD patients.

Suggest specific monitoring strategies or interventions based on lipid levels and creeping fat.

Reinforce the potential impact of integrating lipid metabolism and creeping fat assessment on patient outcomes.

Clinical Report: Lipid Metabolism and Creeping Fat in Crohn's Disease